
        <!DOCTYPE html>
    <html lang="ja">
    <style>
    body
    {
        color: black;
        background-color: white;
    }
    div{
        font-size: 14px;
    }
    span
    {
        font-size: 18px;
    }
    #grad1{
        background: linear-gradient(transparent 60%,#99e4f1 30%);
        font-size: 18px;
        font-weight: bold;
    }
    #grad2{
        background: linear-gradient(transparent 60%,#fda1a1 30%);
        font-size: 18px;
        font-weight: bold;
    }

    </style>

    <head>
        <meta charset="UTF-8">
        <title>103-270</title>
    </head>

    <body>
        <h1>
        <a href="./103_269.html" rel="external" title="prev">≪</a>
        103-270
        <a href="./103_271.html" rel="external" title="next">≫</a>
        </h1>
        <div class='problem'>
            <p>
                <span id="grad1">　問題文　</span>
            </p>
            <p>
                <p>23歳男性。幼児期に喘息と診断され、総合病院の呼吸器内科でテオフィリンが処方され、継続的に服用している。最近、体調を崩し、近所の内科を受診したところ、マイコプラズマ肺炎と診断され、以下の薬剤が投薬された。</p>
<p>服用を始めて2日後、男性は夜中に眠れなくなったので、薬剤情報提供書を薬局に持参してかかりつけ薬剤師に相談した。</p>
<p><img alt="" class="alignnone size-full wp-image-3252" height="219.79999999999998" loading="lazy" sizes="(max-width: 649px) 100vw, 649px" src="data:;base64,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" width="454.29999999999995"/></p>
<h4>問270</h4>
<p>相談された薬剤師は、テオフィリンとの薬物相互作用による副作用を疑い、内科医に疑義照会した。その際、薬剤師が変更を提案すべき薬剤はどれか。1つ選べ。</p>
<ol><li>シプロフロキサシン錠</li><li>カルボシステイン錠</li><li>アンブロキソール塩酸塩錠</li><li>チペピジンヒベンズ酸塩錠</li><li>モンテルカスト錠</li></ol>
<h4>問271</h4>
<p>前問における薬物相互作用の機序として正しいのはどれか。1つ選べ。</p>
<ol><li>CYP1A2の阻害</li><li>CYP3A4の誘導</li><li>有機カチオントランスポーターの阻害</li><li>P-糖タンパク質の阻害</li><li>キレートの形成</li></ol>    
            </p>
        </div>
        <hr>

        <input type="button" value="check ans" onclick="toggle_switch()"/>
        
        <div id='toggle'>
        <div class='answer'>
            <p>
                <span id="grad2">　解答　　</span>
            </p>
            <p>
            問270：1問271：1
            </p>
        </div>
        <div class='description'>
            <p>
                <span id="grad2">　解説　　</span>
            </p>
            <h4>問270</h4>
<p>問271 とまとめて解説します。</p>
<h4>問271</h4>
<p><span style="font-weight: 400;">テオフィリン継続使用中の男性です。</span><span style="font-weight: 400;">テオフィリンといえば、</span><span style="font-weight: 400;">気管支ぜん息薬、キサンチン誘導体です。</span><span style="font-weight: 400;">気管支が広がって楽になる薬といった程度が</span><span style="font-weight: 400;">浮かべばよいと思われます。</span><span style="font-weight: 400;">また、過去問から、</span><span style="font-weight: 400;"><strong>CYP1A2</strong> で代謝される薬</span><span style="font-weight: 400;">であることは</span><span style="font-weight: 400;">思い出したいポイントです。</span></p>
<p><span style="font-weight: 400;">シプロフロキサシンは、</span><span style="font-weight: 400;">ニューキノロン系の抗菌薬です。</span><span style="font-weight: 400;">DNAジャイレース阻害薬です。</span><span style="font-weight: 400;">※ CYP1A2 阻害が知られている薬</span><span style="font-weight: 400;">です。</span></p>
<p><span style="font-weight: 400;">カルボシステイン、アンブロキソールは、</span><span style="font-weight: 400;">共に 去痰薬です。</span></p>
<p><span style="font-weight: 400;">チペピジンヒベンズ酸は、</span><span style="font-weight: 400;">非麻薬性中枢性鎮咳薬です。</span></p>
<p><span style="font-weight: 400;">モンテルカストは、</span><span style="font-weight: 400;">LT受容体拮抗薬です。</span><span style="font-weight: 400;">喘息に用いられます。</span></p>
<p><span style="font-weight: 400;">以上より、</span><span style="font-weight: 400;">問270 の正解は 1 です。<br/></span><span style="font-weight: 400;">問271 の正解は 1 です。</span><span style="font-weight: 400;"><br/></span><span style="font-weight: 400;">類題　，</span></p>
            </p>
        </div>
        </div>
    </body>
    <script>
    document.getElementById("toggle").style.display="none";
    function toggle_switch(){
        var x = document.getElementById("toggle");
        if (x.style.display=="block"){
            x.style.display="none";
        }
        else{
            x.style.display="block";
        }
    }
    </script>
    